1. Home
  2. MKC vs GH Comparison

MKC vs GH Comparison

Compare MKC & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McCormick & Company Incorporated

MKC

McCormick & Company Incorporated

HOLD

Current Price

$51.48

Market Cap

14.3B

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$89.76

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKC
GH
Founded
1889
2011
Country
United States
United States
Employees
14100
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
13.3B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MKC
GH
Price
$51.48
$89.76
Analyst Decision
Buy
Strong Buy
Analyst Count
10
19
Target Price
$67.00
$119.79
AVG Volume (30 Days)
5.1M
2.1M
Earning Date
03-31-2026
05-07-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$16.24
$33.30
Revenue Next Year
$3.71
$28.27
P/E Ratio
$23.90
N/A
Revenue Growth
N/A
32.88
52 Week Low
$47.52
$36.36
52 Week High
$78.03
$120.74

Technical Indicators

Market Signals
Indicator
MKC
GH
Relative Strength Index (RSI) 39.99 50.09
Support Level $47.52 $82.33
Resistance Level $69.16 $90.28
Average True Range (ATR) 1.46 5.39
MACD 0.38 0.55
Stochastic Oscillator 37.15 59.57

Price Performance

Historical Comparison
MKC
GH

About MKC McCormick & Company Incorporated

In its 135-plus-year history, McCormick has become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond consumers, McCormick's customer base includes quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers. Its reach is extensive, with nearly 40% of sales generated beyond its home turf to 150 countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula, among others.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: